Abstract
In the drug discovery cascade, metabolism studies should be performed as early as possible to allow an early evaluation of the metabolism profiles of drug candidates. To help design new drug candidates with improved pharmacokinetics, the knowledge of the site of metabolism is necessary. Computational or in silico metabolism approaches can be broadly classified into (i) ligand-based methods, and (ii) structure-based methods. This review highlight tools used to predict P450-mediated metabolism including ligand-based and structure-based approaches. Some examples of successful application of an integrated in silico approach for the prediction of Phase I metabolism for some flavonoids and lead compounds are presented. Moreover, an integrated in silico approach for the prediction of P450- mediated metabolism is described.
Keywords: Cytochrome P450, docking, drug discovery, ligand-based, metabolism, prediction, structure-based.
Current Drug Metabolism
Title:In silico Prediction of Drug Metabolism by P450
Volume: 15 Issue: 5
Author(s): Carolina H. Andrade, Diego C. Silva and Rodolpho C. Braga
Affiliation:
Keywords: Cytochrome P450, docking, drug discovery, ligand-based, metabolism, prediction, structure-based.
Abstract: In the drug discovery cascade, metabolism studies should be performed as early as possible to allow an early evaluation of the metabolism profiles of drug candidates. To help design new drug candidates with improved pharmacokinetics, the knowledge of the site of metabolism is necessary. Computational or in silico metabolism approaches can be broadly classified into (i) ligand-based methods, and (ii) structure-based methods. This review highlight tools used to predict P450-mediated metabolism including ligand-based and structure-based approaches. Some examples of successful application of an integrated in silico approach for the prediction of Phase I metabolism for some flavonoids and lead compounds are presented. Moreover, an integrated in silico approach for the prediction of P450- mediated metabolism is described.
Export Options
About this article
Cite this article as:
Andrade H. Carolina, Silva C. Diego and Braga C. Rodolpho, In silico Prediction of Drug Metabolism by P450, Current Drug Metabolism 2014; 15 (5) . https://dx.doi.org/10.2174/1389200215666140908102530
DOI https://dx.doi.org/10.2174/1389200215666140908102530 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Tissue Distribution and Metabolism of Micro- and Nanoparticles and Medical Implants
With the continuous advancement of modern science and engineering, numerous functional materials and active molecules have been developed and utilized in various industrial, medical, and food applications. Many of these can enter the body, either actively or passively, and have significant and intricate impacts on human health. For example, biomaterials ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Interlocked Systems in Nanomedicine
Current Topics in Medicinal Chemistry Endothelial Dysfunction: Methods of Assessment & Implications for Cardiovascular Diseases
Current Pharmaceutical Design Extracellular Matrix and Aberrant Signaling in Lung Carcinoma: Role of Fibronectin in the Control of Human Lung Carcinoma Cell Growth,Apoptosis and Resistance to Therapy
Current Signal Transduction Therapy Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis
Current Drug Targets Current Algorithms for the Diagnosis of wide QRS Complex Tachycardias
Current Cardiology Reviews Platelets in Atherothrombosis: New and Evolving Roles
Current Pharmaceutical Design Beneficiary and Adverse Effects of Phytoestrogens: A Potential Constituent of Plant-based Diet
Current Pharmaceutical Design Metabolic Features Across the Female Life Span in Women with PCOS
Current Pharmaceutical Design Structure-Function Relationships of Iodinated Contrast Media and Risk of Nephrotoxicity
Current Medicinal Chemistry Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
Current Medicinal Chemistry PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile
Current Pharmaceutical Design Pharmacological Therapy in Children with Atrioventricular Reentry: Which Drug?
Current Pharmaceutical Design Key miRNAs in Modulating Aging and Longevity: A Focus on Signaling Pathways and Cellular Targets
Current Molecular Pharmacology Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations
CNS & Neurological Disorders - Drug Targets Modulation of the Rho/ROCK Pathway in Heart and Lung after Thorax Irradiation Reveals Targets to Improve Normal Tissue Toxicity
Current Drug Targets Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets Pleiotropic Effects of Simvastatin on Some Calcium Regulatory and Myofibrillar Proteins in Ischemic/Reperfused Heart: Causality of Statins Cardioprotection?
Current Pharmaceutical Design Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine
Current Pharmaceutical Design Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews Highest Mortality During the Last Year Before and the First Year After Start of Dialysis Treatment in Type 2 Diabetic Patients with Nephropathy
Current Diabetes Reviews